Abstract

Breast cancer is a significant global health concern, and early detection remains crucial for improving patient outcomes. Recent advancements in biomarker research and diagnostic technologies have revolutionized breast cancer diagnosis, offering more accurate and timely detection methods. This article reviews innovative biomarkers and early detection tools for breast cancer, including genetic markers, circulating tumor cells, imaging techniques, and liquid biopsies. It discusses their clinical utility, challenges in implementation, and future directions in enhancing early diagnosis and personalized treatment strategies. Understanding these innovations is essential for optimizing
screening programs and improving survival rates through early intervention